The Future of Innovation
Patient Advocacy Groups Briefing
Jim Rosack, PharmD, MS, Senior Science Writer for Psychiatric News will serve as our moderator for this program. Jim is a healthcare journalist and pharmacologist with an extensive background in clinical patient care and medical education and training. (Read more)
David G. Badman, PhD, Pilot Program Officer for NIH Rapid Access to Intervention Development (RAID). The RAID program is designed to assist academic investigators in developing therapeutic agents. He also advises the Director, DKUHD, on hematologist scientific issues, and on policy and administrative matters. (Read more)
J. Leonard Lichtenfeld, MD, FACP, Deputy Chief Medical Officer for the American Cancer Society. Dr. Lichtenfeld is responsible for directing the Society's Cancer Control Science Department and is recognized as a resource both within and outside the Society for his expertise in oncology and medical affairs. (Read more)
Christopher-Paul Milne, DVM, MPH, JD, Assistant Director with Tufts Center for the Study of Drug Development. Dr. Milne researches legal and regulatory issues affecting pharmaceutical and biopharmaceutical development and related health care issues. His current research efforts are directed at examining initiatives for pediatric and orphan disease R&D. (Read more)
Video Excerpts Jim Rosack, PharmD, MS
"Innovation in Mental Health Pharmacology"
David G. Badman, PhD
"The NIH-RAID Pilot – A Roadmap Project (Rapid Access to Interventional Development)"
J. Leonard Lichtenfeld, MD, FACP
"Oncology and Innovation: Time for Some Real Breakthroughs?"
Christopher-Paul Milne, DVM, MPH, JD
"Change and Challenge in Drug Development: What Will it Take?"
Presentations
Jim Rosack, PharmD, MS
"The Promise & Price of Innovation: Treating Mental Illness"
David G. Badman, PhD
"The NIH-RAID Pilot – A Roadmap Project (Rapid Access to Interventional Development)"
"Rare Diseases Clinical Research Network"
J. Leonard Lichtenfeld, MD, FACP
"Oncology and Innovation: Time for Some Real Breakthroughs?"
Christopher-Paul Milne, DVM, MPH, JD
"Change and Challenge in Drug Development: What Will it Take?"
